Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trial
Ashutosh Lal(Post Graduate Institute of Medical Education and Research), Vip Viprakasit(Siriraj Hospital), Hui Shao(University of Louisville), Noppacharn Uaprasert(Chulalongkorn University), Ferras Alashkar(Essen University Hospital), Sujit Sheth(Columbia University Irving Medical Center), Lauren Czapla(Agios Pharmaceuticals (United States)), Antonis Kattamis, Khaled M. Musallam(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Kevin H.M. Kuo(University Health Network), Keely Gilroy(Agios Pharmaceuticals (United States)), Hanny Al‐Samkari(Harvard University), Manuela Balocco(Ospedale Microcitemico), Anita W. Rijneveld(Erasmus MC Cancer Institute), Bart J. Biemond(Amsterdam University Medical Centers), Alì Taher(American University of Beirut Medical Center), Efthymia Vlachaki(Senologic Hellenic Society), Andreas Glenthøj(University of Copenhagen), Nattiya Teawtrakul(Khon Kaen University), Adisak Tantiworawit(Ente Ospedaliero Ospedali Galliera), Jeremie H. Estepp(St. Jude Children's Research Hospital)
Cited by 2
Related Papers
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Thalassaemia
|The Lancet|2017|763
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
|Journal of Thrombosis and Haemostasis|2012|498
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320